Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)

China flag China · Delayed Price · Currency is CNY
25.94
+0.08 (0.31%)
At close: Dec 5, 2025
-9.65%
Market Cap 40.26B
Revenue (ttm) 77.54B
Net Income (ttm) 2.99B
Shares Out 1.63B
EPS (ttm) 1.84
PE Ratio 14.12
Forward PE 13.86
Dividend 0.80 (3.09%)
Ex-Dividend Date Sep 12, 2025
Volume 9,460,560
Average Volume 10,234,715
Open 25.80
Previous Close 25.86
Day's Range 25.70 - 25.95
52-Week Range 24.56 - 29.64
Beta 0.29
RSI 43.62
Earnings Date Mar 16, 2026

About SHA:600332

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials. The company operates through Great Southern TCM, Great Commerce, Great Health, and Other segments. It is also involved in the wholesale, retail, sale, import, and export of Western and Chinese medicines, medical instruments, pharmaceutical products, medical apparatus, and healthcare products; research... [Read more]

Sector Healthcare
Founded 1997
Employees 28,048
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600332
Full Company Profile

Financial Performance

In 2024, SHA:600332's revenue was 74.99 billion, a decrease of -0.69% compared to the previous year's 75.52 billion. Earnings were 2.84 billion, a decrease of -30.09%.

Financial Statements

News

There is no news available yet.